Do you want to read an article? Please log in or register.
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
Migraine and Headache
RECOMMENDED
Related content
RECOMMENDED
Migraine and Headache
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Headache.
American Headache Society
doi: 10.1111/head.13456.
RECOMMENDED
Migraine and Headache
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
Cephalalgia.
Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J, International Headache Society Clinical Trials Standing Committee
doi: 10.1177/0333102419828967.
Migraine and Headache
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
Headache
Ailani J, Burch RC, Robbins MS, Board of Directors of the American Headache Society.
doi: 10.1111/head.14153
Migraine and Headache
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache
Headache
Marmura MJ, Diener HC, Cowan RP, Tepper SJ, Diamond ML, Starling AJ, Hirman J, Mehta L, Brevig T, Cady R
doi: 10.1111/head.14206
COMMENTED
Migraine and Headache
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Cephalalgia.
Buse DC, Lipton RB, Hallström Y, Reuter U, Tepper SJ, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA
doi: 10.1177/0333102418789072.
RECOMMENDED
Migraine and Headache
Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Cephalalgia.
Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Houle TT, Hoek TCVD, Martinelli D, Terwindt GM, International Headache Society Clinical Trials Committee
doi: 10.1177/0333102420941839.
Migraine and Headache
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Headache
Kawata AK, Shah N, Poon JL, Shaffer S, Sapra S, Wilcox TK, Shah S, Tepper SJ, Dodick DW, Lipton RB
doi: 10.1111/head.14053
RECOMMENDED
Migraine and Headache
A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache.
Lombard L, Ye W, Nichols R, Jackson J, Cotton S, Joshi S
doi: 10.1111/head.13835.
Migraine and Headache
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine
Cephalalgia
Tassorelli C, Diener HC, Silberstein SD, Dodick DW, Goadsby PJ, Jensen RH, Magis D, Pozo-Rosich P, Yuan H, Martinelli D, Hoek TVD, Deen M, Ashina M, Terwindt GM
doi: 10.1177/03331024211010413